Literature DB >> 26770638

Development, reliability and validity of the psychosocial adaptation scale for Parkinson's disease in Chinese population.

Tingting Zhang1, Anchun Yin2, Xiaohong Sun1, Qigui Liu3, Guirong Song3, Lianhong Li1.   

Abstract

OBJECTIVE: To develop psychosocial adaptation scale for Parkinson's disease (PD) in Chinese population and evaluate its reliability and validity.
METHODS: The items were designed by literature review, expert consultation and semi-structured interview. The methods of corrected item-total correlation, discrimination analysis and exploratory factor analysis were used for items selection. 427 valid scales from PD patients were collected in the study to test the reliability and validity.
RESULTS: The scale incorporated six dimensions: anxiety, self-esteem, attitude, self-acceptance, self-efficacy and social support, a total of 32 items. The scale possessed good internal consistency. The test-retest correlation coefficient was 0.99 and average content validation rate was 0.97. The Hoehn and Yahr stage were correlated with total score of the scale.
CONCLUSIONS: The psychosocial adaptation scale in this study showed good reliability and validity, it can be used as a reliable and valid instrument to evaluate the psychosocial adaptation of PD objectively and effectively.

Entities:  

Keywords:  Parkinson’s disease; psychosocial adaptation; reliability; scale; validity

Year:  2015        PMID: 26770638      PMCID: PMC4694538     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

1.  PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures.

Authors:  V Peto; C Jenkinson; R Fitzpatrick
Journal:  J Neurol       Date:  1998-05       Impact factor: 4.849

Review 2.  The clinical spectrum of anxiety in Parkinson's disease.

Authors:  Nadeeka N N W Dissanayaka; Elizabeth White; John D O'Sullivan; Rodney Marsh; Nancy A Pachana; Gerard J Byrne
Journal:  Mov Disord       Date:  2014-07       Impact factor: 10.338

3.  Psychosocial factors in Parkinson's disease.

Authors:  B MacCarthy; R Brown
Journal:  Br J Clin Psychol       Date:  1989-02

Review 4.  The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.

Authors:  Chun-lin Ma; Li Su; Juan-juan Xie; Jian-xiong Long; Peng Wu; Lian Gu
Journal:  J Neural Transm (Vienna)       Date:  2013-09-22       Impact factor: 3.575

5.  Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39)

Authors:  C Jenkinson; V Peto; R Fitzpatrick; R Greenhall; N Hyman
Journal:  Age Ageing       Date:  1995-11       Impact factor: 10.668

6.  Quality of life in patients with Parkinson's disease: development of a questionnaire.

Authors:  A G de Boer; W Wijker; J D Speelman; J C de Haes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

7.  Development of a psychosocial adaptation questionnaire for Chinese patients with visual impairments.

Authors:  Xiu-jie Zhang; Ai-ping Wang
Journal:  J Clin Nurs       Date:  2011-10       Impact factor: 3.036

Review 8.  The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential.

Authors:  K Ray Chaudhuri; L Yates; P Martinez-Martin
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

9.  Social support and psychological outcome in people with Parkinson's disease: Evidence for a specific pattern of associations.

Authors:  Jane Simpson; Katrina Haines; Godwin Lekwuwa; John Wardle; Trevor Crawford
Journal:  Br J Clin Psychol       Date:  2006-11

10.  Cross-cultural validity, reliability, and psychometric properties of the persian version of the scales for outcomes in Parkinson's disease-psychosocial questionnaire.

Authors:  Seyed-Mohammad Fereshtehnejad; Farzaneh Farhadi; Hasti Hadizadeh; Gholam Ali Shahidi; Ahmad Delbari; Johan Lökk
Journal:  Neurol Res Int       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.